Cyberwrite boosts Markel Europe’s cyber risk tech

Published 03/06/2025, 14:40
Cyberwrite boosts Markel Europe’s cyber risk tech

NEW YORK - Cyberwrite, a company specializing in cyber risk modeling, has broadened its collaboration with Markel Insurance, part of Markel Group Inc. (NYSE:MKL), to advance underwriting and cyber risk analysis capabilities across Europe. Markel, with a market capitalization of $24.84 billion and a P/E ratio of 14.38, has maintained strong financial metrics according to InvestingPro data, including a healthy current ratio of 2.83.

The extended partnership leverages Cyberwrite’s AI technology to provide Markel Europe’s underwriters with enhanced tools for assessing risk exposures and delivering insights to brokers and clients. This integration offers Markel Europe access to predictive cyber risk analytics for any business globally, aiming to reduce loss ratios and facilitate data-driven underwriting in a matter of seconds.

Nir Perry, CEO and Founder of Cyberwrite, expressed pride in their role as a technology provider for Markel and noted that the expanded partnership addresses historical challenges in cyber insurance underwriting and modeling. He highlighted the AI-driven technology’s ability to quantify the economic impact and likelihood of cyber claims with detailed precision.

Cyberwrite’s platform translates complex cyber risk data into business insights, enabling insurance professionals to effectively communicate the potential economic impact of cyber incidents. The platform also allows for real-time benchmarking against industry peers and supports Cyberwrite’s next-generation catastrophe modeling solution.

The company’s data collection covers over 99.97% of businesses globally, enabling risk reports for nearly any organization at the time of underwriting in eight different languages.

Frederik Wulff, CEO of Markel Europe, commented on the transformative impact of Cyberwrite’s platform on their evaluation of cyber risk, particularly for small and mid-sized businesses. The ability to quantify previously unmeasurable factors in real-time and in local languages has improved brokers’ explanations of cyber risks to clients and has enhanced clients’ understanding of their cyber insurance needs.

This press release statement indicates that Cyberwrite and Markel Europe are working together to enhance the precision and efficiency of cyber risk evaluation and insurance underwriting across European markets.

In other recent news, Markel Group Inc. reported a significant miss in its first-quarter 2025 earnings, with earnings per share at $12.08, falling short of the expected $17.4, and revenue at $3.4 billion, below the forecasted $3.89 billion. This earnings report highlights the challenges Markel is facing, as the company navigates a transitional year with plans to streamline operations and focus on premium growth in the latter half of 2025. Meanwhile, Argus Research upgraded Markel’s stock rating to Buy from Hold, citing the company’s strategic acquisitions and commitment to underwriting profitability, despite concerns over inconsistent returns on equity and the absence of dividend payments.

Additionally, Markel UK announced a leadership change with Lee Mooney set to take over as managing director, pending regulatory approval, following Neil Galjaard’s departure. At the recent annual shareholder meeting, Markel shareholders voted on key proposals, electing directors and approving executive compensation, while rejecting a proposal for a report on greenhouse gas emissions. The company also ratified KPMG LLP as its independent auditor for the fiscal year ending December 31, 2025.

In another development, Argus adjusted the price target for Bio-Techne Corp. to $65.00 from $90.00, while maintaining a Buy rating, reflecting a more cautious outlook despite continued confidence in the stock’s potential. These recent developments highlight the ongoing adjustments and strategic focus within Markel and the broader insurance and investment sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.